Terug
35
39
Dagbereik
€ 8,56
€ 10,31
52-Weeksbereik
€ 6,91
€ 17,86
Volume
100
50D / 200D Gem.
€ 8,56
/
€ 8,56
Vorige Slotkoers
€ 8,56
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,1 | 0,2 |
| P/B | 0,0 | 3,0 |
| ROE % | 13,2 | 3,6 |
| Net Margin % | 9,9 | 3,8 |
| Rev Growth 5Y % | 14,1 | 9,9 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,00
€ 0,98 – € 1,01
|
89,91B | 1 |
| FY2029 |
€ 0,88
€ 0,86 – € 0,89
|
82,67B | 1 |
| FY2028 |
€ 0,65
€ 0,64 – € 0,66
|
76,56B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-01-30 | € 0,01 | -€ 0,03 | -544,6% |
| 2025-10-27 | € 0,04 | € 0,09 | +133,5% |
| 2025-07-29 | € 0,18 | € 0,33 | +79,4% |
| 2025-04-28 | € 0,16 | € 0,18 | +9,0% |
| 2025-01-29 | € 0,04 | € 0,01 | -70,6% |
| 2024-10-29 | € 0,08 | € 0,04 | -49,2% |
| 2024-07-26 | € 0,18 | € 0,23 | +23,9% |
| 2024-04-26 | € 0,23 | € 0,22 | -6,6% |
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,29%
Growth (3Y)
30,21%
Growth (5Y)
19,29%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Mar 30, 2026 | € 0,21 | 2,41% |
| Mar 31, 2025 | Jun 23, 2025 | € 0,19 | 1,06% |
| Mar 28, 2024 | Jun 24, 2024 | € 0,13 | 0,74% |
| Mar 30, 2023 | Jun 26, 2023 | € 0,11 | 0,44% |
| Mar 30, 2022 | Jun 27, 2022 | € 0,09 | 0,31% |
| Mar 30, 2021 | Jun 21, 2021 | € 0,09 | 0,37% |
| Mar 30, 2020 | Jun 22, 2020 | € 0,08 | 0,35% |
| Mar 27, 2019 | Jun 20, 2019 | € 0,07 | 0,30% |
| Mar 28, 2018 | Jun 22, 2018 | € 0,12 | 0,55% |
| Mar 29, 2017 | Jun 23, 2017 | € 0,10 | 0,44% |
| Mar 29, 2016 | Jun 27, 2016 | € 0,06 | 0,28% |
| Mar 27, 2015 | Jun 25, 2015 | € 0,06 | 0,26% |
| Mar 27, 2014 | Jun 23, 2014 | € 0,10 | 0,44% |
| Mar 27, 2013 | Jun 24, 2013 | € 16,95 | 75,68% |
| Mar 28, 2012 | Jun 18, 2012 | € 14,50 | 64,74% |
| Mar 29, 2011 | Jun 20, 2011 | € 12,14 | 54,18% |
| Mar 29, 2010 | Jun 21, 2010 | € 5,40 | 24,09% |
| Mar 26, 2009 | Jun 22, 2009 | € 10,12 | 45,17% |
Belangrijkste Punten
Revenue grew 14,10% annually over 5 years — strong growth
Earnings declined -16,23% over the past year
ROE of 13,22% — decent returns on equity
Debt/Equity of 0,17 — conservative balance sheet
Generating 1,74B in free cash flow
P/E of 0,12 — trading at a low valuation
Groei
Revenue Growth (5Y)
14,10%
Revenue (1Y)12,93%
Earnings (1Y)-16,23%
FCF Growth (3Y)542,14%
Kwaliteit
Return on Equity
13,22%
ROIC8,58%
Net Margin9,93%
Op. Margin10,39%
Veiligheid
Debt / Equity
0,17
Current Ratio1,61
Interest Coverage62,72
Waardering
P/E Ratio
0,12
Forward P/E16,60
P/B Ratio0,01
EV/EBITDA-1,17
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,93% | Revenue Growth (3Y) | 1231,62% |
| Earnings Growth (1Y) | -16,23% | Earnings Growth (3Y) | -2,79% |
| Revenue Growth (5Y) | 14,10% | Earnings Growth (5Y) | 5,97% |
| Profitability | |||
| Revenue (TTM) | 60,95B | Net Income (TTM) | 6,05B |
| ROE | 13,22% | ROA | 7,91% |
| Gross Margin | 88,35% | Operating Margin | 10,39% |
| Net Margin | 9,93% | Free Cash Flow (TTM) | 1,74B |
| ROIC | 8,58% | FCF Growth (3Y) | 542,14% |
| Safety | |||
| Debt / Equity | 0,17 | Current Ratio | 1,61 |
| Interest Coverage | 62,72 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,29% |
| Dividend Growth (3Y) | 30,21% | Dividend Growth (5Y) | 19,29% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0,12 | Forward P/E | 16,60 |
| P/B Ratio | 0,01 | P/S Ratio | 0,01 |
| PEG Ratio | -2,65 | Forward PEG | N/A |
| EV/EBITDA | -1,17 | Fwd EV/EBITDA | -0,31 |
| Forward P/S | 0,01 | Fwd Earnings Yield | 6,02% |
| FCF Yield | 246,94% | ||
| Market Cap | 702,61M | Enterprise Value | -7,42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 60,95B | 53,97B | 343,74M | 38,90B | 35,96B |
| Net Income | 6,05B | 7,23B | 6,41B | 5,41B | 4,80B |
| EPS (Diluted) | 70,95 | 82,74 | 73,13 | 61,77 | 54,86 |
| Gross Profit | 53,85B | 47,54B | 280,04M | 262,57M | 269,85M |
| Operating Income | 6,34B | 8,27B | 7,28B | 6,32B | 5,47B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 76,54B | 72,48B | 490,12M | 464,94M | 447,46M |
| Total Liabilities | 29,22B | 28,19B | 200,91M | 218,55M | 242,37M |
| Shareholders' Equity | 47,32B | 44,28B | 38,42B | 29,99B | 22,66B |
| Total Debt | 8,05B | 6,43B | 8,33B | 10,37B | 13,52B |
| Cash & Equivalents | 16,18B | 18,24B | 121,71M | 116,05M | 91,80M |
| Current Assets | 38,66B | 37,78B | 32,55B | 27,82B | 23,22B |
| Current Liabilities | 23,99B | 21,33B | 18,02B | 16,21B | 13,88B |
Strategiescores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#547 of 826
#271 of 619
Recente Activiteit
Uitgestapt
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Ingestapt
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Defensive Investing (Benjamin Graham)
Mar 24, 2026